Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPHA | FENC | ABOS | ||
| Company | Innate Pharma S.A. ADR | Fennec Pharmaceuticals Inc | Acumen Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.22 | 6.44 | 2.90 | ||
| High | 2.25 | 6.46 | 2.94 | ||
| Low | 2.22 | 6.27 | 2.83 | ||
| Last | 2.25 | 6.40 | 2.92 | ||
| Change | +0.10 | +0.01 | +0.05 | ||
| % Change | +4.65% | +0.16% | +1.74% | ||
| Volume | 1,561 | 13,387 | 84,604 | ||
| 20-Day Average Volume | 8,523 | 105,359 | 703,326 | ||
| Previous Close | 2.15 | 6.39 | 2.87 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.10 | 6.23 | 2.54 | ||
| 20-Day Raw Stochastic | 71.43% | 60.10% | 74.11% | ||
| 20-Day Relative Strength | 49.32% | 44.49% | 54.01% | ||
| Weighted Alpha | -27.38 | -21.14 | -54.37 | ||
| Today's Opinion | 88% Sell | 80% Sell | 40% Sell | ||
| Previous Opinion | 88% Sell | 80% Sell | 40% Sell | ||
| Last Month's Opinion | 48% Sell | 88% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.13% since 07/15/24 | -1.99% since 07/15/24 | +0.52% since 07/15/24 | ||
| Low | 2.12 on 07/19/24 | 6.26 on 07/18/24 | 2.79 on 07/19/24 | ||
| High | 2.25 on 07/22/24 | 6.91 on 07/17/24 | 3.20 on 07/17/24 | ||
| 1-Month | |||||
| %Chg | +5.14% since 06/21/24 | -0.16% since 06/21/24 | +25.97% since 06/21/24 | ||
| Low | 1.92 on 06/28/24 | 5.66 on 07/05/24 | 2.08 on 06/26/24 | ||
| High | 2.38 on 07/12/24 | 6.91 on 07/17/24 | 3.20 on 07/17/24 | ||
| 3-Month | |||||
| %Chg | -7.22% since 04/22/24 | -31.66% since 04/22/24 | -7.03% since 04/22/24 | ||
| Low | 1.92 on 06/28/24 | 5.66 on 07/05/24 | 2.08 on 06/26/24 | ||
| High | 3.05 on 05/23/24 | 10.07 on 05/13/24 | 3.92 on 05/20/24 | ||
| 6-Month | |||||
| %Chg | -15.25% since 01/22/24 | -37.46% since 01/22/24 | -14.16% since 01/22/24 | ||
| Low | 1.92 on 06/28/24 | 5.66 on 07/05/24 | 2.08 on 06/26/24 | ||
| High | 3.15 on 04/08/24 | 11.49 on 03/21/24 | 5.09 on 03/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 174,079 | 174,626 | 172,430 | ||
| Shares Outstanding, K | 80,967 | 27,328 | 60,080 | ||
| Annual Sales | 66,710,000 | 21,250,000 | 0 | ||
| Annual Net Income | -8,190,000 | -16,050,000 | -52,370,000 | ||
| Last Quarter Sales | N/A | 25,380,000 | 0 | ||
| Last Quarter Net Income | N/A | 12,840,000 | -14,870,000 | ||
| 60-Month Beta | 0.38 | 0.29 | 0.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.41 on 05/14/24 | -0.25 on 05/14/24 | ||
| Latest Earnings Date | 05/14/24 | 08/01/24 | 08/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 211.33 | 0.00 | ||